Commentary on the results and clinical implications of the PROactive study

Robert Rizza; Robert Henry; Richard Kahn

doi:10.2337/diaclin.24.2.66

Commentary on the results and clinical implications of the PROactive study

Robert Rizza, Robert Henry, Richard Kahn

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	66-68
Number of pages	3
Journal	Clinical Diabetes
Volume	24
Issue number	2
DOIs	https://doi.org/10.2337/diaclin.24.2.66
State	Published - Apr 2006

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.2337/diaclin.24.2.66

Cite this

@article{335456bc09744d869164e0f87cd60e1b,

title = "Commentary on the results and clinical implications of the PROactive study",

author = "Robert Rizza and Robert Henry and Richard Kahn",

year = "2006",

month = apr,

doi = "10.2337/diaclin.24.2.66",

language = "English (US)",

volume = "24",

pages = "66--68",

journal = "Clinical Diabetes",

issn = "0891-8929",

publisher = "American Diabetes Association Inc.",

number = "2",

}

TY - JOUR

T1 - Commentary on the results and clinical implications of the PROactive study

AU - Rizza, Robert

AU - Henry, Robert

AU - Kahn, Richard

PY - 2006/4

Y1 - 2006/4

UR - http://www.scopus.com/inward/record.url?scp=33646234440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646234440&partnerID=8YFLogxK

U2 - 10.2337/diaclin.24.2.66

DO - 10.2337/diaclin.24.2.66

M3 - Comment/debate

AN - SCOPUS:33646234440

SN - 0891-8929

VL - 24

SP - 66

EP - 68

JO - Clinical Diabetes

JF - Clinical Diabetes

IS - 2

ER -

Commentary on the results and clinical implications of the PROactive study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this